Table 3.
Variables | A/A (n = 85) | A/G+G/G (n = 17) | P Valuea |
---|---|---|---|
Gender | 0.05 | ||
Male | 56 (65.88) | 7 (41.18) | |
Female | 29 (34.12) | 10 (58.82) | |
Age (year) | 53.12 ± 11.09 | 55.05 ± 10.07 | 0.71 |
ABO Compatibility | 0.22 | ||
Compatible | 70 (82.35) | 16 (94.12) | |
Incompatible | 15 (17.65) | 1 (5.88) | |
Original disease | 0.74 | ||
HCV | 29 (34.12) | 8 (47.06) | |
HBV | 18 (21.18) | 3 (17.65) | |
Autoimmune disease | 10 (11.76) | 1 (5.88) | |
Others | 28 (32.94) | 5 (29.41) | |
MELD | 18.08 ± 8.68 | 18.70 ± 7.94 | 0.47 |
Child‐Turcotte‐Pugh | 0.61 | ||
A | 6 (7.06) | 2 (11.76) | |
B | 30 (34.12) | 4 (23.53) | |
C | 50 (58.82) | 11 (64.71) | |
Donor | 0.74 | ||
Parent | 5 (5.88) | 1 (5.88) | |
Child | 47 (55.29) | 12 (70.59) | |
Sibling | 13 (15.29) | 1 (5.88) | |
Spouse | 18 (21.18) | 3 (17.65) | |
Others | 2 (2.35) | 0 (0) | |
HLA total mismatches | 3.49 ± 1.60 | 3.58 ± 1.41 | 0.97 |
HLA Class I mismatches | 2.41 ± 1.06 | 2.41 ± 1.06 | 0.90 |
HLA Class II mismatch | 1.13 ± 0.69 | 1.17 ± 0.63 | 0.84 |
GRWR | 0.90 ± 0.21 | 0.85 ± 0.17 | 0.26 |
GRWR, graft‐to‐recipient weight ratio; HBV, hepatitis B virus; HCV, hepatitis C virus; LDLT, Living donor liver transplantation; MELD, model for end‐stage liver disease; SD, standard deviation
Categorical variables are presented as number (%), while continuous variables are presented as mean ± SD.
Pearson's chi‐squared test/ Wilcoxon rank sum tests, a difference was considered significant if P‐value was < 0.05.
Typed HLA antigens: HLA‐A1, HLA‐A2, HLA‐B1, HLA‐B2, HLA‐DR1, and HLA‐DR2.